SPTA1 anticorps (AA 356-475)

N° du produit ABIN6654217

Détail du produit anti-SPTA1 anticorps

Antigène: SPTA1 (Spectrin alpha Chain, Erythrocytic 1 (SPTA1))

Épitope: AA 356-475

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SPTA1 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)

Purification: Purified

Pureté: Protein G affinity chromatography

Immunogène: A portion of amino acids 356-475 from the human protein was used as the immunogen for the recombinant SPTA1 antibody.

Clone: SCNA-1R

Isotype: IgG1 kappa

Information d'application

Indications d'application: The stated application concentrations are suggested starting points. Titration of the recombinant SPTA1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.

1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Western blot: 1-2 μg/mL,Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)

Restrictions: For Research Use only

Stockage

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the recombinant SPTA1 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).

Détails sur SPTA1

Antigène: SPTA1 (Spectrin alpha Chain, Erythrocytic 1 (SPTA1))

Autre désignation: SPTA1 / Spectrin alpha 1 (SPTA1 Produits)

Sujet: This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [RefSeq]